SERPINB9 and cancer: Overexpression of serpin B9 in various cancer cell lines results in resistance to killing by cytotoxic lymphocytes and, critically, is associated with resistance to immune checkpoint blockade in murine melanoma as well as against radiotherapy-induced type I interferon signalling (104, 108–112).